April 7, 2022 - … for all FDA-approved amyloid-beta targeting therapies. For lecanemab, our partner Eisai has initiated FDA filing via the … for all FDA-approved amyloid-beta targeting therapies. For lecanemab, our partner Eisai has initiated FDA filing via the … for all FDA-approved amyloid-beta targeting therapies. For lecanemab, our partner Eisai has initiated FDA filing via the …